Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques


In order to develop a successful subunit vaccine against infection with the human immunodeficiency virus (HIV), protective immune effector functions must be identified. Until now, there has been only indirect evidence that HIV-specific cytotoxic T lymphocytes (CTLs) fulfill this role. Using the macaque simian immunodeficiency virus (SIV) model, the protective potential of nef-specific CTLs, stimulated by vaccination, was examined in animals challenged with a high intravenous dose of the pathogenic simian immunodeficiency virus, SIVmac251(32H)(pJ5). An inverse correlation was found between the vaccine-induced nef-specific CTL precursor frequency and virus load measured after challenge. In addition, the early decline in viraemia, observed in both vaccinated and unvaccinated control animals was associated with the development of virus-specific CTL activity and not with the presence of virus-specific neutralizing antibodies. The results imply that vaccines that stimulate strong CTL responses could protect against HIV infection.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1

    Bangham, C.R.M. & McMichael, A.J. in T Cells (eds Feldmann, M., Lamb, J. & Owen, M. J.) 281–310 (Wiley, New York, 1989).

  2. 2

    Lukacher, A.E., Braciale, V.L. & Braciale, T.J. In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific. J exp. Med. 160, 814–826 (1984).

  3. 3

    McMichael, A.J. & Walker, B. Cytotoxic T lymphocyte epitopes: Implications for HIV vaccines. AIDS (suppl.) 8, S155–S173 (1994).

  4. 4

    Koup, R. et al. Temporal association of cellular immune responses with the initial control of viraemia in primary human immunodeficiency virus type 1 syndrome. J. virol. 68, 4650–4655 (1994).

  5. 5

    Walker, C.M., Moody, D.J., Stites, D.P. & Levy, J.A. CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234, 1563–1566 (1986).

  6. 6

    Tsubota, H.C., Lord, C.I., Watkins, D.I., Morimoto, C. & Letvin, N.L. A cytotoxic T lymphocyte inhibits acquired immunodeficiency syndrome virus replication in peripheral blood lymphocytes. J. exp. Med. 169, 1421–1434 (1989).

  7. 7

    Mackewicz, C.E., Ortega, H.W. & Levy, J.A. CD8+ cell anti-HIV activity correlates with the clinical state of the infected individual. J. clin. Invest. 87, 1462–1466 (1991).

  8. 8

    Kannagi, M., Chalifoux, L.V., Lord, C.I. & Letvin, N.L. Suppression of simian immunodeficiency virus replication in vitro by CD8+ lymphocytes. J. Immun. 140, 2237–2242 (1988).

  9. 9

    Rowland-Jones, S. et al. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med. 1, 59–64 (1995).

  10. 10

    Chakrabarti, L. et al. Sequence of simian immunodeficiency virus from macaque and its relationship to other human and simian retroviruses. Nature 328, 543–547 (1987).

  11. 11

    Letvin, N. et al. Induction of AIDS-like disease in macaque monkeys with T-cell tropic retrovirus STLV-III. Science 230, 71–73 (1985).

  12. 12

    Kestler, H. et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 65, 651–662 (1991).

  13. 13

    Rud, E. et al. Molecular and biological characterization of simian immunodeficiency virus macaque strain 32H proviral clones containing nef size variants. J. Gen. Viral. 75, 529–543 (1994).

  14. 14

    Rud, E. et al. Infectious molecular clones of SIVmac32H: Nef deletion controls ability to re-isolate virus from rhesus macaques. Vaccines 92: Modem Approaches to New Vaccines including AIDS (eds F. Brown, R.M. Chanock, H.S. Ginsberg, and R.A. Lerner) 239–245 (Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, 1992).

  15. 15

    Daniel, M.D., Kirchhoff, F., Czajak, S.C., Sehgal, P.K. & Desrosiers, R.C. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 258, 1938–1941 (1992).

  16. 16

    Robert-Guroff, M. et al. Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages. J. Viral. 64, 3391–3398 (1990).

  17. 17

    Bachmann, M.-F. et al. Induction of protective cytotoxic T cells with viral proteins. Eur. J. Immun. 24, 2228–2236 (1994).

  18. 18

    Cao, Y., Qin, L., Zhang, L., Safrit, J. & Ho, D. Virologic and immunologic characterisation of long-term survivors of human immunodeficiency virus type 1 infection. New Engl. J. Med. 332, 201–208 (1995).

  19. 19

    Pantaleo, G. et al. Studies in subjects with Long-term nonprogressive human immunodeficiency virus infection. New Eng. J. Med. 332, 209–216 (1995).

  20. 20

    Ariyoshi, K. et al. HIV-2-specific cytoxic T-lymphocyte activity is inversely related to proviral load. AIDS 9, 555–559 (1995).

  21. 21

    Yasutomi, Y., Reimann, K.A., Lord, C.I., Miller, M.D. & Letvin, N.L. Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys. J. Virol. 67, 1707–1711 (1993).

  22. 22

    Brinchmann, J.E., Gaudernack, G. & Vartdal, F. CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells: Evidence for a soluble inhibitor. J. Immun. 144, 2961–2966 (1990).

  23. 23

    Gotch, P.M., Nixon, D.F., Alp, N., McMichael, A.J. & Borysiewicz, L.K. High frequency of memory and effector gag specific cytotoxic T lymphocytes in HIV seropositive individuals. Int. Immun. 2, 707–712 (1990).

  24. 24

    Abimuku, A.G. et al. HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques. Nature Med. 1, 321–329 (1995).

  25. 25

    Culmann, B., Gomard, E. & Kieny, M.-P. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 nef protein. J. Immun. 146, 1560–1565 (1991).

  26. 26

    Culmann-Penciolelli, B. et al. Identification of multirestricted immunodominant regions recognised by cytolytic T lymphocytes in the human immunodeficiency virus type 1 nef protein. J. Virol. 68, 7336–7343 (1994).

  27. 27

    Bourgault, I. et al. Simian immunodeficiency virus as a model for vaccination against HIV. J. Immun. 152, 2530–2537 (1994).

  28. 28

    Lamhamedi-Cherradi, S.C. et al. Qualitative and quantitative analysis of human cytotoxic T lymphocyte responses to HIV-1 proteins. AIDS 6, 1249–1258 (1992).

  29. 29

    Nowak, M.A. et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature (in the press).

  30. 30

    Rowland-Jones, S. & McMichael, A.J. Cell-mediated immune responses in HIV-exposed individuals: Have they cleared the virus? Curr. Topics Immun. (in the press).

  31. 31

    Gotch, F., Hovell, R., Delchambre, M., Silvera, P. & McMichael, M., T-cell responses to simian immunodeficiency virus by cynomolgus macaque monkeys immunized with recombinant vaccinia virus. AIDS 5, 317–320 (1991).

  32. 32

    Townsend, A. et al. Defective presentation to class 1 restricted cytotoxic T lymphocytes in vaccinia infected cells is overcome by enhanced degradation of antigen. J. exp. Med. 168, 1211–1224 (1988).

  33. 33

    Norusis, M.J. SPSS/PC+ V2.0 (SPSS Inc., Chicago, Illinois, 1988).

  34. 34

    Lefkovits, I. & Waldmann, H. Limiting dilution analysis of cells in the immune system (Cambridge University Press, Cambridge, 1979).

  35. 35

    Rose, J., Silvera, P., Flanagan, B., Kitchin, P. & Almond, N. The development of PCR-based assays for the detection and differentiation of simian immunodeficiency virus in vivo. J. Virol. Methods 51, 229–239 (1995).

  36. 36

    Bootman, J. & Kitchin, P. An international collaborative study to assess a set of reference reagents for HIV-1 PCR. J. Virol. Methods 37, 23–42 (1992).

  37. 37

    Sambrook, J., Fritsch, E. & Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd edn (Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1989).

  38. 38

    Saluz, H. & Jost, J.A. A simple high-resolution procedure to study DNA methylation and in vivo DNA-protein interactions on a single copy gene level in higher eukaryotes. Proc. natn. Acad. Sci. U.S.A. 86, 2602–2626 (1989).

  39. 39

    An, S., Franklin, D. & Fleming, K. Generation of dioxygenin-labelled double-stranded probes using the polymerase chain reaction. Molec. Cell Probes 6, 193–200 (1992).

  40. 40

    Bootman, J.S. & Kitchen, P.A. Reference preparations in the standardisation of HIV. l PCR: An international collaborative study. J. Virol. Methods 49, 1–8 (1994).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Gallimore, A., Cranage, M., Cook, N. et al. Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nat Med 1, 1167–1173 (1995). https://doi.org/10.1038/nm1195-1167

Download citation

Further reading